| Patient | Srinivasa Ramanujan |
|---|---|
| Date of birth | 1996-12-22 |
| Identifiers | MRN HR-ET020-SYN; SSN (made up) 000-20-1937 |
| Document date | 2026-03-16 |
| Author | Edmund Ashworth, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Sore throat, runny nose and cough for three days, and worry that the liver infection has come back. [S]
Mr. Ramanujan called this morning and was seen the same day. Three days ago he developed a sore throat, then a runny nose, sneezing and a dry cough; last night his temperature was 37.9 °C. Two students in his seminar have had colds this week. He has had no pain under the right ribs, no night sweats, no loss of appetite and no diarrhea, and his weight is still rising. He was frightened that the fever meant the abscess had returned and asked to be checked. He is in his third week of rifampin and taking it each morning; his urine and tears are orange, as he was told they would be, and he has had no nausea, rash or yellowing of the eyes. He is still going to counseling each week. [S]
| Element | Detail |
|---|---|
| Onset | Three days ago |
| Duration | Three days |
| Character | Sore throat, runny nose, sneezing, dry cough |
| Severity | Mild; highest temperature 37.9 °C |
| Context | Colds in his seminar; six weeks after amebic liver abscess treatment; rifampin for latent tuberculosis |
| Modifying factors | Warm drinks; acetaminophen once |
| Associated signs and symptoms | No right upper quadrant pain, night sweats, weight loss or diarrhea |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Low fever to 37.9 °C; no night sweats; appetite good |
| Ears, nose, mouth, and throat | Positive | Sore throat, runny nose, sneezing |
| Respiratory | Positive | Dry cough; no breathlessness, chest pain or blood in the sputum |
| Gastrointestinal | Negative | No abdominal pain, nausea or diarrhea |
| Eyes | Negative | Orange tears as expected on rifampin; no yellowing |
| Psychiatric | Positive | Worried about a relapse; mood otherwise better; no thoughts of self-harm |
6 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Metronidazole 250 mg oral tablet, three tablets (750 mg) three times a day with food for 10 days | Three tablets every 8 hours with food for 10 days | Oral route | 2026-01-14 to 2026-01-23 | completed | S |
| Paromomycin 250 mg oral capsule, two capsules (500 mg) three times a day with meals for 7 days, started the day after metronidazole ends | Two capsules every 8 hours with meals for 7 days | Oral route | 2026-01-24 to 2026-01-30 | completed | S |
| Vitamin B12 (cyanocobalamin) 1,000 microgram oral tablet, one tablet daily | One tablet daily | Oral route | 2026-01-14 | active | S |
| Cholecalciferol 50,000 unit (1.25 mg) oral tablet, one tablet once a week for 8 weeks | One tablet once a week for 8 weeks | Oral route | 2026-01-14 to 2026-03-04 | completed | S |
| Cholecalciferol 2,000 unit (50 microgram) oral tablet, one tablet daily, from the end of the weekly course | One tablet daily | Oral route | 2026-03-05 | active | S |
| Rifampin 300 mg oral capsule, two capsules (600 mg) once daily on an empty stomach for 4 months | Two capsules each morning before breakfast for 4 months | Oral route | 2026-02-23 | active | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-16 | Body height | 165 | cm | S |
| 2026-03-16 | Body weight | 55.2 | kg | S |
| 2026-03-16 | Body mass index (BMI) [Ratio] | 20.3 | kg/m2 | S |
| 2026-03-16 | Systolic blood pressure | 114 | mm[Hg] | S |
| 2026-03-16 | Diastolic blood pressure | 70 | mm[Hg] | S |
| 2026-03-16 | Heart rate | 88 | /min | S |
| 2026-03-16 | Respiratory rate | 16 | /min | S |
| 2026-03-16 | Body temperature | 37.8 | Cel | S |
| 2026-03-16 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
|---|---|---|---|---|---|---|
| 2026-03-16 | Leukocytes [#/volume] in Blood by Automated count | 7.4 | 10*3/uL | 4-11 10*3/uL | Normal | S |
| 2026-03-16 | C reactive protein [Mass/volume] in Serum or Plasma | 11 | mg/L | <=5 mg/L | High | S |
| 2026-03-16 | Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma | 104 | U/L | 40-129 U/L | Normal | S |
| 2026-03-16 | Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma | 32 | U/L | 7-41 U/L | Normal | S |
| 2026-03-16 | Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] | 7 | {score} | S |
Vital signs recorded on 2026-03-16; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Well, a little tired; temperature 37.8 °C, pulse 88, oxygen saturation 98% on room air |
| Ears, nose, and throat | Pharynx mildly red without exudate; nasal mucosa swollen; tympanic membranes normal |
| Neck | No enlarged nodes |
| Respiratory | Clear on both sides, including the right base |
| Abdomen | Liver not tender or enlarged; no tenderness over the right lower ribs |
| Skin | No rash or jaundice |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| Evening fevers to 38.6 °C with night sweats for about four weeks | resolved | confirmed | R50.9 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Weight loss of 5 kg over two months (57 to 52 kg), with poor appetite | resolved | confirmed | R63.4 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Dull right upper quadrant pain for three weeks, worse on deep breathing and lying on the right side, with a tender liver edge | resolved | confirmed | R10.11 | S — Synthetic presenting symptom, superseded by the diagnosis at the second visit. |
| Amebic liver abscess: a single 6.2 x 5.4 cm abscess in the right lobe (segment VII) on ultrasound, Entamoeba histolytica antibody positive, blood cultures negative, years after two episodes of dysentery in India; treated with metronidazole and then paromomycin; synthetic modern diagnosis linked to the hepatic amoebiasis later proposed for his illness | active | confirmed | A06.4 | S — Synthetic modern diagnosis; it does not settle the historical diagnostic conflict (CLM-0010, CLM-0011). |
| Vitamin B12 deficiency from a strict vegetarian diet (B12 168 pg/mL), with anemia (hemoglobin 11.2 g/dL, MCV 99 fL) to which inflammation also contributes | active | confirmed | D51.3 | S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed. |
| Vitamin D deficiency (25-hydroxyvitamin D 9 ng/mL) | active | confirmed | E55.9 | S — Synthetic finding anchored to his documented diet and the vitamin deficiency later proposed. |
| Positive interferon-gamma release assay, with chest radiograph and sputum smears and NAAT negative for tuberculosis; cultures pending | resolved | confirmed | R76.12 | S — Synthetic finding, superseded by the diagnosis of latent infection when cultures were negative. |
| Latent tuberculosis infection: positive interferon-gamma release assay, normal lungs on the radiograph, three sputum smears, NAAT and cultures negative; treated with four months of rifampin | active | confirmed | Z22.7 | S — Synthetic modern diagnosis; active tuberculosis was excluded, which does not settle the historical question. |
| Adjustment disorder with depressed mood (PHQ-9 12, no thoughts of self-harm) during a serious illness, far from his wife and family | active | confirmed | F43.21 | S — Synthetic modern diagnosis anchored to his documented loneliness; not a claim about his real mental health. |
| Acute viral upper respiratory infection, three weeks into rifampin and six weeks after treatment of the liver abscess, without signs of abscess relapse; resolved | active | confirmed | J06.9 | S — Synthetic intercurrent illness; not a historical claim. |
Guideline basis: Guidelines for the Treatment of Latent Tuberculosis Infection: Recommendations from the National Tuberculosis Controllers Association and CDC, 2020 (2020); DPDx: Amebiasis (laboratory diagnosis, including antibody detection in extraintestinal disease) (2026); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024)
Follow-up: Call for fever beyond three days, right upper quadrant pain or breathlessness. Preventive visit in three weeks as booked. Next scheduled visit 2026-04-06: periodic adult preventive visit with pre-travel advice. [S]